Parnassus Investments, an investment management company, released the “Parnassus Core Equity Fund” fourth quarter 2024 ...

We recently published a list of 12 Best Quality Stocks to Invest in Now. In this article, we are going to take a look at ...

Eli Lilly (LLY) shares snapped six straight days of losses as the stock closed 1.39% higher, at $812.76 on Friday. The ...

Eli Lilly and Company (NYSE:LLY) showcased strong financial performance in its Q4 2023 Earnings Call, reporting a 20% revenue... Eli Lilly and Company (NYSE:LLY) showcased strong financial ...

In trading on Monday, shares of Eli Lilly (Symbol: LLY) crossed below their 200 day moving average of $855.24, changing hands as low as $839.51 per share. Eli Lilly shares are currently trading ...

Investors in Eli Lilly (Symbol: LLY) saw new options become available today, for the October 17th expiration. One of the key inputs that goes into the price an option buyer is willing to pay ...

Eli Lilly said Wednesday it will invest $27 billion to build four new manufacturing plants in the United States as the pharmaceutical giant grapples with the threat of drug import duties from the ...

Eli Lilly (NYSE:LLY) recently announced its plans to invest $27 billion in four new U.S. manufacturing plants over the next five years, creating thousands of jobs. This move comes at a time when ...

Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include ...

Eli Lilly (LLY) joins hands with Magnet Biomedicine in a deal worth up to $1.25B to develop cancer drugs using Magnet's innovative TrueGlue platform. Read more here.

INDIANAPOLIS - Eli Lilly and Company (NYSE: NYSE:LLY) announced today that Anat Ashkenazi has resigned from her position as Chief... Alphabet (NASDAQ:GOOGL) has appointed Anat Ashkenazi as its new ...